Find trials
Consejos para buscar

A Study to Assess a Multicenter Cancer Biospecimen Collection

Overview

Información sobre este estudio

This is a retrospective specimen acquisition study of pre-treatment head and neck squamous cell carcinoma tumor biopsy samples.  The sponsor-provided protocol allows for multiple different tumor types.  However, Mayo Clinic, Rochester will only enroll head and neck squamous cell carcinoma.

 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Subject must have a disease of interest. Specifically, subject must have one of:
    • head and neck squamous cell carcinoma (HNSCC);
    • non-small-cell lung cancer (NSCLC);
    • small cell lung cancer (SCLC);
    • urothelial carcinoma (UCC);
    • gastric or gastroesophageal junction adenocarcinoma;
    • cervical cancer;
    • esophageal squamous cell carcinoma (ESCC);
    • triple-negative breast cancer (TNBC); 
    • hepatocellular carcinoma (HCC);
    • renal cell carcinoma (RCC);
    • colorectal cancer (CRC).
  • Subject must have received, or be scheduled to receive, at least one dose of anti-PD-1/PD-L1 immunotherapy for treatment of their cancer.
  • Subject must have had, or will have, a tumor biopsy prior to treatment with anti-PD-1/PD-L1 immunotherapy.
  • Subject must have undergone, or will undergo, medical imaging (e.g., CT or MRI) of the tumor prior to treatment with anti-PD-1/PD-L1 immunotherapy.
  • Willing to provide electronic informed consent per IRB-approved protocol.
  • Able to speak, read, and comprehend English fluently.
  • Subject is 18 years of age or older.
  • Subjects must have sufficient tissue available to fulfill the specimen requirements of the study, as defined in the SPECIMENS TO BE COLLECTED section of this protocol.

Exclusion Criteria:

  • Inability or unwillingness to provide informed consent.
  • Subject who does/did not have one of the cancers listed above (other histologies).
  • Subject has already participated in this trial.

 

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Katharine Price, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20529234

Mayo Clinic Footer